EC to take actions against drug-resistant infections
Posted by webmaster on November 18th, 2011 02:22 PM | No CommentPfizer’s orphan drug Vyndaqel approved in EU
Posted by Edward Su on November 17th, 2011 05:29 PM | No Comment
The European Commission has granted Pfizer the marketing right of Vyndaqel (tafamidis) for the treatment of transthyretin familial amyloid polyneuropathy (TTR-FAP) in adult patients with stage 1 symptomatic polyneuropathy. The decision followed the positive opinion of CHMP earlier this summer.
TTR-FAP ...
